# K181482: myTAP2

- Pathway: 510(k) (Traditional)
- Applicant: Airway Management, Inc.
- Decided: Aug 31, 2018 after 87 days
- Product code: LRK (Device, Anti-Snoring)
- Device class: 2
- Regulation: 21 CFR 872.5570
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K071404 (2007). 11 ancestors in all.
No later device cites it as a predicate yet.
0 of 12 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K170825: SnoreRx, Apnea Sciences Corporation (2017) Summary page 4.

## Indications for use
The myTAP2 is intended for use on adult patients 18 years of age or older as an aid for the reduction of snoring.

Source page: https://510kreport.com/device/K181482
Methodology: https://510kreport.com/methodology